Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GI bleeding risk in ibuprofen users not increased by alcohol use, Whitehall maintains.

This article was originally published in The Tan Sheet

Executive Summary

IBUPROFEN GI BLEEDING RISK NOT INCREASED BY ALCOHOL, WHITEHALL ASSERTS in an Oct. 23 letter to FDA on whether OTC ibuprofen products should bear an alcohol use warning. Whitehall-Robins, the maker of Advil, has long opposed alcohol warnings on ibuprofen-containing OTCs. Responding to an Oct. 2 letter to FDA by McNeil Consumer Products, Whitehall disputes conclusions the Tylenol (acetaminophen) marketer draws from a study by Boston University School of Medicine's Slone Epidemiology Unit on analgesics, alcohol and upper gastrointestinal bleeding. "Contrary to the assertions in McNeil's Oct. 2 letter to the docket, significant clinical and epidemiologic data show that OTC ibuprofen has excellent GI tolerability," the Advil marketer asserts.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087773

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel